Interested stakeholders have until 13 December 2021 to submit comments on draft International Council for Harmonisation guidance that the US Food and Drug Administration has published for feedback.
The FDA summarized that the Q13 Continuous Manufacturing of Drug Substances and Drug Products
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?